David Agdashian

2.0k total citations
6 papers, 343 citations indexed

About

David Agdashian is a scholar working on Oncology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Agdashian has authored 6 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Immunology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in David Agdashian's work include Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers) and Heart Failure Treatment and Management (1 paper). David Agdashian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers) and Heart Failure Treatment and Management (1 paper). David Agdashian collaborates with scholars based in United States and South Korea. David Agdashian's co-authors include Tim F. Greten, Milan Sandhu, Firouzeh Korangy, Bernd Heinrich, Zachary J. Brown, Qianfei Zhang, Qiong Fu, Chi Ma, Su Jong Yu and Umberto Rosato and has published in prestigious journals such as Journal of Hepatology, Cancer Immunology Immunotherapy and Current Gene Therapy.

In The Last Decade

David Agdashian

6 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Agdashian United States	4	201	174	86	74	44	6	343
Milan Sandhu United States	3	201 1.0×	172 1.0×	86 1.0×	70 0.9×	44 1.0×	4	330
Ka‐Wo Chan China	7	127 0.6×	144 0.8×	14 0.2×	190 2.6×	45 1.0×	8	376
Hongcheng Sun China	9	110 0.5×	34 0.2×	54 0.6×	214 2.9×	37 0.8×	19	395
Rikke B. Holmstroem Denmark	6	197 1.0×	143 0.8×	9 0.1×	61 0.8×	21 0.5×	10	280
Justin Taylor United States	3	58 0.3×	111 0.6×	29 0.3×	108 1.5×	22 0.5×	7	288
Gabriel Champenois France	7	129 0.6×	118 0.7×	13 0.2×	114 1.5×	17 0.4×	10	270
Pengfei Sun China	13	73 0.4×	70 0.4×	42 0.5×	178 2.4×	40 0.9×	24	328
Shu-Jung Hsu China	8	68 0.3×	49 0.3×	43 0.5×	118 1.6×	64 1.5×	13	279
Priyam Mitra United States	3	322 1.6×	211 1.2×	7 0.1×	63 0.9×	50 1.1×	5	383
Hongliang Guo China	10	120 0.6×	61 0.4×	19 0.2×	243 3.3×	46 1.0×	20	400

Countries citing papers authored by David Agdashian

Since Specialization

Citations

This map shows the geographic impact of David Agdashian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Agdashian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Agdashian more than expected).

Fields of papers citing papers by David Agdashian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Agdashian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Agdashian. The network helps show where David Agdashian may publish in the future.

Co-authorship network of co-authors of David Agdashian

This figure shows the co-authorship network connecting the top 25 collaborators of David Agdashian. A scholar is included among the top collaborators of David Agdashian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Agdashian. David Agdashian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Agdashian, David & Lori B. Daniels. (2023). What Is the Clinical Utility of Cardiac Troponins in Heart Failure? Are They Modifiable Beyond Their Prognostic Value?. Current Heart Failure Reports. 20(1). 33–43. 2 indexed citations

2.

Agdashian, David, Mei ElGindi, Changqing Xie, et al.. (2019). The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 68(4). 599–608. 103 indexed citations

3.

Brown, Zachary J., Su Jong Yu, Bernd Heinrich, et al.. (2018). Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma. Cancer Immunology Immunotherapy. 67(8). 1305–1315. 101 indexed citations

4.

Yu, Su Jong, Chi Ma, Bernd Heinrich, et al.. (2018). Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Journal of Hepatology. 70(3). 449–457. 125 indexed citations

5.

Ma, Chao, Bernd Heinrich, Zarin Brown, et al.. (2018). Cytokine-induced killer cells recruit myeloid derived suppressor cells in HCC, which can be targeted by a PDE5 inhibitor. Journal of Hepatology. 68. S95–S96. 1 indexed citations

6.

Davtyan, Hayk, Armine Hovakimyan, Karen Zagorski, et al.. (2014). BTX AgilePulse<sup>TM</sup> System is an Effective Electroporation Device for Intramuscular and Intradermal Delivery of DNA Vaccine. Current Gene Therapy. 14(3). 190–199. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact